When Joseph Broderick was a college sophomore in 1975, stroke treatment was a waiting game. Doctors could diagnose a stroke but couldn’t stop it. There were no scientifically proven therapies, no ...
Clinical Trials Arena on MSN
Silver Creek’s stroke hopeful yields mixed results in Phase II trial
If approved, the targeted IGF-1 fusion protein would become the only treatment available for late-window stroke patients beyond reperfusion.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback